GENF
Genflow Bioscience is a UK-based biotech company focused on anti-aging treatments and longevity research, with R&D facilities in Belgium. The company aims to halt or slow aging and extend healthspan in humans and dogs, pursuing novel therapeutic approaches such as the GF-1002 compound that delivers a centenarian variant of the SIRT6 gene. Genflow focuses on pioneering life-extension science and publishes findings through its science and investor channels in the UK and Europe.
No recent news for this company.
No recent deals for this company.